We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+4.62%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$420M
AUM Growth
+$41.9M
Cap. Flow
+$32.2M
Cap. Flow %
7.66%
Top 10 Hldgs %
44.29%
Holding
115
New
10
Increased
24
Reduced
25
Closed

Top Buys

Rank Stock Value
1
CPB icon
Campbell Soup
CPB
+$7.41M
2
GH icon
Guardant Health
GH
+$5.45M
3
PFE icon
Pfizer
PFE
+$4.57M
4
MRK icon
Merck
MRK
+$4.31M
5
KO icon
Coca-Cola
KO
+$4.15M

Sector Composition

Rank Sector Weight
1 Healthcare 22.83%
2 Consumer Staples 14.42%
3 Materials 10.35%
4 Communication Services 10.06%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
101
M&T Bank
MTB
$35.7B
$218K 0.05%
1,500
COST icon
102
Costco
COST
$422B
$216K 0.05%
+547
New +$207K
EPD icon
103
Enterprise Products Partners
EPD
$82.3B
$212K 0.05%
+8,800
New +$208K
LQD icon
104
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$202K 0.05%
+1,500
New +$198K
HL icon
105
Hecla Mining
HL
$9.47B
$200K 0.05%
26,875
+10,000
+59% +$75.1K
BGC icon
106
BGC Group
BGC
$5.45B
$191K 0.05%
33,750
NXE icon
107
NexGen Energy
NXE
$6.06B
$187K 0.04%
45,500
MUX icon
108
McEwen Inc
MUX
$1.03B
$179K 0.04%
12,970
BTG icon
109
B2Gold
BTG
$5B
$130K 0.03%
30,900
AUY
110
DELISTED
Yamana Gold, Inc.
AUY
$87K 0.02%
20,600
TTI icon
111
TETRA Technologies
TTI
$1.14B
$65K 0.02%
+15,000
New +$49.4K
KOR
112
DELISTED
Corvus Gold Inc. Common Shares
KOR
$59K 0.01%
21,500
+3,500
+19% +$8.84K
ASM
113
Avino Silver & Gold Mines
ASM
$934M
$44K 0.01%
38,100
THM
114
International Tower Hill Mines
THM
$458M
$13K ﹤0.01%
12,300
GPL
115
DELISTED
Great Panther Mining Limited
GPL
$7K ﹤0.01%
1,100

Similar funds

Sicart Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Sicart Associates held 115 positions worth $420M, up 11% from $378M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sicart Associates deployed $32.2M of net new capital in Q2 2021, opening 10 new positions and adding to 24 existing holdings. Its largest new stake was Campbell Soup: 153,970 shares worth $7.02M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Materials.

On the sell side, the largest reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, an estimated $2.43M trimmed.

  • Sicart Associates's largest Q2 2021 buy was Campbell Soup: 153,970 shares worth $7.02M.
  • Sicart Associates added most to Pfizer in Q2 2021, an estimated $4.57M increase.
  • Sicart Associates's biggest Q2 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $2.43M.
  • Sicart Associates's ten largest holdings make up 44% of its $420M portfolio in Q2 2021.
  • Sicart Associates opened 10 new positions and closed 0 in Q2 2021.
  • Sicart Associates's portfolio value rose 11% quarter-over-quarter to $420M.

Based on Sicart Associates's 13F filing for Q2 2021, filed 23 Jul 2021.